Evidence map›Paper›PMID 40856872›Full record

ArticleMikrochimica acta2025

A novel NiCaAl-LDH@ND-COOH nanocomposite-modified electrode for highly sensitive and selective electrochemical detection of larotrectinib in pharmaceutical and biological samples.

Elif Naz Öven, Asena Ayse Genc, Nevin Erk, Hassan Elzain Hassan Ahmed, Mustafa Soylak

Abstract read
PubMed Publisher
In one paragraph

Article in Mikrochimica acta, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. A chitosan/rGO/FeRSC advances · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Elif Naz ÖvenDepartment of Analytical Chemistry, Faculty of Pharmacy, Ankara University, 06560, Ankara, Turkey. elifnazoven0@gmail.com.
Asena Ayse GencDepartment of Analytical Chemistry, Faculty of Pharmacy, Ankara University, 06560, Ankara, Turkey.
Nevin ErkDepartment of Analytical Chemistry, Faculty of Pharmacy, Ankara University, 06560, Ankara, Turkey.
Hassan Elzain Hassan AhmedDepartment of Chemistry, Faculty of Sciences, Erciyes University, 38039, Kayseri, Turkey.
Mustafa SoylakDepartment of Chemistry, Faculty of Sciences, Erciyes University, 38039, Kayseri, Turkey.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A novel electrochemical sensor based on a glassy carbon electrode (GCE) modified with a NiCaAl layered double hydroxide with carboxyl-functionalized nanodiamonds (NiCaAl-LDH@ND-COOH) was developed for the first time to enable sensitive and selective detection of larotrectinib (LARO), the first selective pan-tropomyosin receptor kinase (TRK) inhibitor used clinically for cancer treatment. The nanocomposite was synthesized by integrating NiCaAl layered double hydroxide (LDH) with carboxyl-functionalized nanodiamonds (ND-COOH), resulting in enhanced electrocatalytic performance. The individual electrochemical properties of ND-COOH and NiCaAl-LDH were systematically evaluated and compared with those of the combined nanocomposite. ND-COOH contributed high surface area, low background current, and improved conductivity, while NiCaAl-LDH offered abundant redox-active sites and high ion-exchange capacity. The NiCaAl-LDH@ND-COOH nanocomposite exhibited a synergistic enhancement in electron transfer kinetics and surface activity, as evidenced by cyclic voltammetry and impedance studies. Under optimized conditions, the sensor displayed a wide linear detection range (1.0 to 16.37 µM) and a low detection limit of 4.36 nM. It also demonstrated excellent repeatability (RSD = 1.3%), reproducibility (RSD = 1.23%), and high selectivity against common interferents. Successful application to pharmaceutical formulations, serum, and urine samples confirmed its practicality, achieving recoveries between 96.7% and 102.6%. This work provides the first electrochemical sensing platform for LARO, offering a reliable and cost-effective tool for its monitoring in clinical and pharmaceutical settings.

Indexed as

Electrochemical TechniquesNanocompositesPyrazolesPyrimidinesElectrodesHumansHydroxidesLimit of DetectionNickelHydroxideslarotrectinibNickelPyrazolesPyrimidinesDifferential pulse voltammetryElectrochemical sensorLarotrectinib detectionModified glassy carbon electrodeNiCaAl-LDH@ND-COOH nanocompositePharmaceutical samplesTrace analysis

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.